• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640

Research Briefing on Pyridine, 4-(methoxymethyl)- (CAS 70199-60-9) in Chemical and Biomedical Applications

Pyridine, 4-(methoxymethyl)- (CAS 70199-60-9) is a specialized pyridine derivative that has garnered significant attention in recent years due to its versatile applications in chemical synthesis and biomedical research. This compound, characterized by its methoxymethyl functional group, serves as a key intermediate in the synthesis of pharmaceuticals, agrochemicals, and advanced materials. Recent studies have explored its potential in drug discovery, particularly in the development of novel therapeutic agents targeting infectious diseases and cancer.

A 2023 study published in the Journal of Medicinal Chemistry highlighted the role of Pyridine, 4-(methoxymethyl)- as a building block for the synthesis of small-molecule inhibitors targeting bacterial efflux pumps. The research demonstrated that derivatives of this compound exhibited potent activity against multidrug-resistant strains of Pseudomonas aeruginosa, suggesting its potential in addressing antibiotic resistance. The study utilized computational docking and in vitro assays to validate the binding affinity and efficacy of these derivatives.

In the field of oncology, Pyridine, 4-(methoxymethyl)- has been investigated for its utility in the design of kinase inhibitors. A recent preprint on bioRxiv detailed the synthesis of a series of pyridine-based compounds, including 70199-60-9, which showed promising inhibitory effects on tyrosine kinases involved in tumor proliferation. The researchers employed structure-activity relationship (SAR) analysis to optimize the compounds, achieving nanomolar potency in cell-based assays. These findings underscore the compound's potential as a scaffold for anticancer drug development.

Beyond its pharmaceutical applications, Pyridine, 4-(methoxymethyl)- has also been explored in materials science. A 2024 study in Advanced Materials reported its use as a precursor for the synthesis of conductive polymers with applications in flexible electronics. The methoxymethyl group was found to enhance the solubility and processability of the resulting polymers, making them suitable for use in organic electronic devices. This interdisciplinary approach highlights the compound's versatility across multiple domains.

Despite these advancements, challenges remain in the large-scale production and purification of Pyridine, 4-(methoxymethyl)-. Recent patents filed by leading chemical companies have addressed these issues by proposing novel synthetic routes and purification techniques. For instance, a 2023 patent by Merck KGaA described a cost-effective method for the high-yield synthesis of 70199-60-9 using catalytic hydrogenation, which could facilitate its broader adoption in industrial applications.

In conclusion, Pyridine, 4-(methoxymethyl)- (CAS 70199-60-9) represents a valuable compound with diverse applications in chemical and biomedical research. Its role in drug discovery, materials science, and industrial chemistry continues to expand, driven by ongoing innovations in synthesis and application. Future research should focus on further optimizing its derivatives for specific therapeutic and technological needs, as well as addressing scalability challenges to meet growing demand.

• 586-95-8((pyridin-4-yl)methanol)
• 20027-70-7(4-(methoxymethyl)pyridine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)